Advanced Biomed is trading at $3.56, down 5.34% versus the October 21 close, with broad-market pressure appearing more plausible than a company-specific catalyst. - No new company-specific announcement was identified for October 22; full-year results released October 13 do not establish a direct cause for the pre-market decline. - Major U.S. indices and futures are lower amid geopolitical tensions and rising oil prices. Biotech is reported higher pre-market, so it does not explain the drop.